BioCryst Pharmaceuticals, Inc. 3Y Operating CF Growth (CAGR)

3Y Operating CF Growth (CAGR) of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Operating CF Growth (CAGR) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Operating CF Growth (CAGR) for 2021 was 0.0% (a NaN% decrease from previous year)
  • Annual 3Y Operating CF Growth (CAGR) for 2020 was 0.0% (a NaN% decrease from previous year)
  • Annual 3Y Operating CF Growth (CAGR) for 2019 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Operating CF Growth (CAGR) of BioCryst Pharmaceuticals, Inc.

Most recent 3Y Operating CF Growth (CAGR)of BCRX including historical data for past 10 years.

Interactive Chart of 3Y Operating CF Growth (CAGR) of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. 3Y Operating CF Growth (CAGR) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.0%
2020 0.0%
2019 0.0%
2018 0.0%
2017 0.0%
2016 0.0%
2015 0.0%
2014 0.0%
2013 0.0%
2012 0.0%

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology